Growing community of inventors

Arvada, CO, United States of America

Richard A Schmidt

Average Co-Inventor Count = 1.16

ph-index = 9

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 203

Richard A SchmidtZdzislaw Salamon (1 patent)Richard A SchmidtGordon Tollin (1 patent)Richard A SchmidtVictor David Kruppa (1 patent)Richard A SchmidtH Angus Macleod (1 patent)Richard A SchmidtMitchell O Perley (1 patent)Richard A SchmidtRobert A Kuehn (1 patent)Richard A SchmidtThe Regents Of The University Of Colorado, Legal Representative (1 patent)Richard A SchmidtMitchell Q Perley (0 patent)Richard A SchmidtRichard A Schmidt (18 patents)Zdzislaw SalamonZdzislaw Salamon (5 patents)Gordon TollinGordon Tollin (5 patents)Victor David KruppaVictor David Kruppa (5 patents)H Angus MacleodH Angus Macleod (2 patents)Mitchell O PerleyMitchell O Perley (1 patent)Robert A KuehnRobert A Kuehn (1 patent)The Regents Of The University Of Colorado, Legal RepresentativeThe Regents Of The University Of Colorado, Legal Representative (1 patent)Mitchell Q PerleyMitchell Q Perley (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Colorado (10 from 1,381 patents)

2. Other (4 from 832,843 patents)

3. Raytheon Company (2 from 8,187 patents)

4. Allergan, Inc. (1 from 2,285 patents)

5. University Technology Corporation (1 from 80 patents)

6. Schmidt, Richard A. (0 patent)


18 patents:

1. 9066943 - Use of botulinum toxin therapy for treatment of urological neurological conditions

2. 8840905 - Use of neurotoxin therapy for treatment of urologic and related disorders

3. 8445836 - System for maintaining an even temperature distribution across a laser detector

4. 8290726 - Photoconductive photodiode built-in test (BIT)

5. 8062643 - Use of neurotoxin therapy for treatment of urologic and related disorders

6. 8057807 - Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

7. 7981048 - Method and system for diagnosis of lower urinary tract dysregulation and related conditions

8. 7968104 - Use of neurotoxin therapy for treatment of urologic and related disorders

9. 7470431 - Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

10. 7449192 - Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

11. 7431701 - Method and system for diagnosis of lower urinary tract dysregulation and related conditions

12. 7429387 - Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

13. 7153514 - Use of botulinum toxin therapy for prostatic hyperplasia and related disorders

14. 7001602 - Use of botulinum toxin therapy for urinary incontinence and related disorders

15. 6667041 - Use of neurotoxin therapy for treatment of urologic and related disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…